Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease-antibiotic use in the history does not play a significant role

被引:40
|
作者
Prónai, L [1 ]
Schandl, L
Orosz, Z
Magyar, P
Tulassay, Z
机构
[1] Semmelweis Univ, Hungarian Acad Sci, Fac Med, Dept Med 2,Gastroenterol Res Unit, Budapest, Hungary
[2] Semmelweis Univ, Dept Pulmonol, H-1088 Budapest, Hungary
关键词
Helicobacter pylori; inflammatory bowel disease; Crohn's disease; ulcerative colitis; chronic obstructive pulmonary disease;
D O I
10.1111/j.1083-4389.2004.00223.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Patients with inflammatory bowel disease have lower prevalence of Helicobacter pylori infection, but the exact reason for this is not yet clear. Aim. To examine whether the antibiotics frequently used in inflammatory bowel disease are responsible for the lower prevalence of H. pylori infection. Patients with chronic obstructive pulmonary disease on prolonged previous antibiotic therapy were used for comparison. Methods. Presence/absence of H. pylori infection was detected by a C-13-urea breath test in 133 patients with inflammatory bowel disease (82 ulcerative colitis, and 51 Crohn's disease) and compared with that of 135 patients with chronic obstructive pulmonary disease and with two age-matched control groups (200 patients each). Primary disease location, duration of disease and detailed analysis of previous and current medication (dose and duration of antibiotics, steroids, 5-aminosalicylic acid) were analysed in each cases. Results. Seventeen of the 133 patients with inflammatory bowel disease [12.2% (10/82) of ulcerative colitis and 13.7% (7/51) of Crohn's disease] and 90/135 patients with chronic obstructive pulmonary disease (66.7%) were positive for H. pylori. A total of 78/200 (39%) for the inflammatory-bowel-discase-group-matched controls and 110/210 (55%) for the chronic-obstructive-pulmonary-disease-matched controls were positive for H. pylori. The history of any antibiotic or steroid therapy had no influence on H. pylori status of patients with inflammatory bowel disease. Conclusion. The prevalence of H. pylori compared to the age-matched controls is significantly lower in patients with inflammatory bowel disease but not in those with chronic obstructive pulmonary disease. Antibiotic use is not responsible for the lower prevalence of H. pylori infection in patients with inflammatory bowel disease.
引用
收藏
页码:278 / 283
页数:6
相关论文
共 50 条
  • [1] Lower prevalence of Helicobacter pylori is not associated with previous antibiotic use in patients with inflammatory bowel disease
    Pronai, L
    Zagoni, T
    Nemeth, A
    Kovacs, A
    Tulassay, Z
    GASTROENTEROLOGY, 1999, 116 (04) : A799 - A799
  • [2] Does Helicobacter pylori play a role in inflammatory bowel disease?
    Nardone, G
    Rocco, A
    Budillon, G
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 30 (01): : 134 - 137
  • [3] Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease
    Pearce, CB
    Duncan, HD
    Timmis, L
    Green, JRB
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (04) : 439 - 443
  • [4] Prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease
    Hwang, Sang Jun
    Park, Dong Il
    Huh, Kyu Chan
    Choi, Hyo Sun
    Park, Jung Ho
    Kim, Hong Joo
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S434 - S434
  • [5] Prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease
    Park
    Hwang, S. J.
    Huh, K. C.
    Choi, H. S.
    Park, J. H.
    Kim, H. J.
    Cho, Y. K.
    HELICOBACTER, 2006, 11 : 20 - 20
  • [6] Helicobacter pylori infection in chronic obstructive pulmonary disease
    Dayem, Aya M. M. A.
    Afify, Sara A.
    Mohamed, Haitham S. E.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2023, 72 (01): : 12 - 15
  • [7] Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease
    Sonnenberg, A.
    Genta, R. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (04) : 469 - 476
  • [8] Assessment of the prevalence of infection with Helicobacter pylori by patients with Inflammatory Bowel Disease.
    Pearce, CB
    Duncan, HD
    Green, JR
    Timmis, L
    GASTROENTEROLOGY, 2000, 118 (04) : A1291 - A1291
  • [9] Prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease: pilot study
    Pellicano, R.
    Bresso, F.
    Demarchi, B.
    Bertolusso, L.
    Sapone, N.
    Rizzetto, M.
    Astegiano, M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (11) : 676 - 677
  • [10] Helicobacter pylori infection in patients with inflammatory bowel disease
    Guslandi, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (11): : 2570 - 2571